Optoceutics ApS: Financial statements 2021
CVR: 39769689
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Optoceutics ApS (CVR 39769689) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -2,177,118 and a net result of DKK -3,880,378 compared with DKK -506,333 the year before. Equity in the 2021 report amounted to DKK 13,367,310. The solvency ratio was 50.5%. The company had 10 employees in the financial year.
- Gross Profit
- DKK -2,177,118
- Profit/Loss
- DKK -3,880,378
- Equity
- DKK 13,367,310
- Total Assets
- DKK 26,446,127
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -2.2 mio. | -3.9 mio. | 13.4 mio. | 10 |
| 2020 | - | -132 t. | -506 t. | 16.2 mio. | 6 |
Official annual report
Find more companies like Optoceutics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Optoceutics ApS has published its annual report for 2020. Gross profit came to DKK -131,718, and the net result was DKK -506,333.
About Optoceutics ApS
Optoceutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Optoceutics IVS. The management consists of Ngoc Mai Thi Nguyen and Marcus Schultz Carstensen. The board consists of Jes Broeng (chair), Kaare Agerholm Danielsen, Marcus Schultz Carstensen and Ngoc Mai Thi Nguyen. The company's owners include Vjack Holding ApS, M. S. C. HOLDING ApS and Danielsen 2 ApS. According to the 2025 annual report, the company had an average of 7 employees. In 2025, the company reported a gross profit of DKK -2,585,556 and a net result of DKK -8,736,152 compared with DKK -9,184,625 the year before. Equity in the 2025 report amounted to DKK 32,320,160.